5 Best Gas Utility Stocks To Invest In Right Now

 

By John Whitefoot

Whether you’re in Pamplona, Spain or on Wall Street, when it comes to running with the bulls, the object is to stay ahead of the pack. This means not getting gouged physically or financially. However, there are an increasingly large number of investors out there right now who think they’ve got a handle on the bull market.

Why? The Federal Reserve says it won’t taper its generous $85.0-billion-per-month quantitative easing policy until the U.S. economy improves. And by that, it means—for now at least—an unemployment rate of 6.5% and an inflation rate of 2.5%.

As a result, the Federal Reserve’s easy money and artificially deflated near-record low interest rates have put the stock market front and center for income-starved investors looking for capital appreciation. As long as the Fed keeps its printing presses in overdrive, there’s no reason to think that the bull market will take a breather.

5 Best Gas Utility Stocks To Invest In Right Now: Harris Corporation (HRS)

Harris Corporation, together with its subsidiaries, operates as a communications and information technology company that serves government and commercial markets worldwide. It operates in three segments: RF Communications, Government Communications Systems, and Broadcast Communications. The RF Communications segment designs, develops, and manufactures secure radio communications products and systems for manpack, handheld, soldier-worn, vehicular, strategic fixed-site, and shipboard applications that operate in various radio frequency bands. It also offers products and solutions ranging from wireless network infrastructure solutions to portable and mobile single-band and multiband radios, and public safety-grade broadband video and data solutions for the public safety, federal, utility, commercial, and transportation markets. The Government Communications Systems segment develops, supplies, and integrates communications and information processing products, systems, and netw orks for aerospace, terrestrial, and maritime applications supporting department of defense missions. This segment also provides mission-critical communications and information processing systems for the U.S. civilian Federal market, as well as offers IT transformation, managed, and information assurance solutions. The Broadcast Communications segment provides workflow, infrastructure, and networking solutions that enable media companies to streamline workflow from production through transmission; media solutions to manage digital media workflow through software solutions for advertising, media management, digital signage, broadband, digital asset management, and play-out automation; and transmission systems for delivery of media over wireless broadcast terrestrial networks. The company also offers healthcare IT solutions, IT compliance solutions, and mission-critical managed satellite communications services. Harris Corporation was founded in 1895 and is based in Melbourne, Florida.

Advisors' Opinion:

• [By Rich Smith]

  The U.S. Department of Defense awarded nine new contracts on Monday worth some $1.121 billion in aggregate. The largest of these awards, however, swallowed more than 85% of the funds on offer. Split among five publicly traded companies, and one privately owned, this monster IT contract envisions paying out $960 million over the course of time to contractors:

  Lockheed Martin (NYSE: LMT  ) Raytheon (NYSE: RTN  ) Harris� (NYSE: HRS  ) L-3 Communications (NYSE: LLL  ) TYBRIN Corp., a subsidiary of Jacobs Engineering Group (NYSE: JEC  ) SRA International

  The multiple award, indefinite- delivery/indefinite-quantity (IDIQ) contract was awarded under the U.S. Air Force's Network-Centric Solutions-2 (NETCENTS-2) Application Services program, which the Air Force describes as being one of its primary vehicles for purchasing "sustainment, migration, integration, training, help desk support, testing and operational support" services. Over the course of the contract, the six named contactors will be the only ones entitled to bid (against each other) for task orders awarded under the umbrella IDIQ contract.

5 Best Gas Utility Stocks To Invest In Right Now: Patterson Companies Inc.(PDCO)

Patterson Companies, Inc. operates as a distributor serving the dental, companion-pet veterinarian, and rehabilitation supply markets in North America. Its Dental Supply segment provides consumable dental supplies, such as x-ray film and solutions; impression and restorative materials; hand instruments; sterilization products; anesthetics; infection control products, including protective clothing, gloves, and facemasks; paper, cotton, and disposable products; toothbrushes; dental accessories; printed office products, office filing supplies, and practice management systems; x-ray machines, handpieces, dental chairs and handpiece control units, diagnostic equipment, dental lights, compressors, chair-side restoration systems, and inter-oral cameras; practice management and clinical software; hardware and networking solutions; and patient education solutions. The company?s Veterinary Supply segment offers consumable supplies, such as lab supplies, paper goods, needles and syr inges, gauze and wound dressings, sutures, latex gloves, and orthopedic and casting products; pharmaceuticals comprising anesthetics, antibiotics, ointments, and nutraceuticals; diagnostics; biologicals, including vaccines and injectibles; and equipment and software. Its Rehabilitation Supply segment provides dressing and grooming devices, and toileting, dining, and bathing aids; braces, splints, and orthotics; exercise bands, putty, weight balls, and mats; walkers, canes, and wheelchair accessories; rolls, wedges, seating and standers, and mobility assistance products; motor stimulation products; products for heating and cooling therapies, electrical stimulation, laser, ultrasound, paraffin, iontophoresis, and therapeutic creams and lotions; and rehabilitation equipment and software. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is based in St. Paul , Minnesota.

Advisors' Opinion:

• [By Eric Volkman]

  Patterson (NASDAQ: PDCO  ) has elected not to raise its quarterly shareholder payout. The company today declared a regular stock dividend of $0.16 per share, to be paid on July 26 to shareholders of record as of July 11. That amount matches the company's previous distribution, which was paid at the end of April. Before that, Patterson handed out $0.14 per share.

Top New Stocks To Own For 2015: VCA Antech Inc (WOOF)

VCA Antech, Inc., incorporated on May 4, 1987, is a national animal healthcare company operating in the United States and Canada. The Company provides veterinary services and diagnostic testing to support veterinary cares. The Company operates in two segments: animal hospital and laboratory. Its all other category includes Vetstreet and Medical Technology operating segments. The Company sells diagnostic imaging equipment and other medical technology products and related services to the veterinary markets. The Company's animal hospitals offer a range of general medical and surgical services for companion animals, as well as specialized treatments, including advanced diagnostic services, internal medicine, oncology, ophthalmology, dermatology and cardiology. On January 31, 2012, it expanded its operations into Canada with an increased investment in Associate Veterinary Clinics (1984) Limited (AVC), which operates 44 hospitals in three Canadian provinces. On February 1, 2012, it acquired ThinkPet's, Inc. (ThinkPets). In 2012, it acquired 79 animal hospitals, including 44 with the acquisition of AVC, one laboratory and ThinkPets.

The Company provides various communication, marketing solutions and other services to the veterinary community. The Company's network of animal hospitals is supported by more than 3,000 veterinarians and had approximately 7.4 million patient visits during the year ended December 31, 2012. The Company's network of veterinary diagnostic laboratories provides testing and consulting services used by veterinarians in the detection, diagnosis, evaluation, monitoring, treatment and prevention of diseases and other conditions affecting animals. The Company's network of veterinary diagnostic laboratories provides diagnostic testing for over 16,000 clients, which includes standard animal hospitals, large animal practices, universities and other government organizations. The Company's medical technology business sells digital radiography and ultrasound imaging equipment, provid! es education and training on the use of that equipment, and provides consulting and mobile imaging services.

The Company's Vetstreet business provides services to veterinary practices, pharmaceutical manufacturers, and the pet owning community. The Company's services to veterinary practices include subscriptions to the Company's Pro Pet Portals. The Pro Pet Portal provides an online platform for the veterinarian to offer secure individualized portals for pet owners, as well as practice Websites that are branded to the individual veterinary clinic. The Company also sells appointment reminder notices that are sent to pet owners on behalf of their clinics. The Company's services to manufacturers involve targeted marketing programs to animal hospitals whom are subscribers to the Company's Pro Pet Portal.

Animal Hospital

As of December 31, 2012, the Company operated 609 animal hospitals serving 41 states and three Canadian provinces. The Company's Animal Hospital revenue accounted for 78% of total revenue in 2012. In addition to general medical and surgical services, the Company offers specialized treatments for companion animals, including advanced diagnostic services, internal medicine, oncology, ophthalmology, dermatology and cardiology. The Company also provides pharmaceutical products for uses in the delivery of treatments by its veterinarians and pet owners. Many of the Company's animal hospitals offer additional services, including grooming, bathing and boarding. The Company also sells specialty pet products at its animal hospitals, including pet food, vitamins, therapeutic shampoos and conditioners, flea collars and sprays, and other accessory products.

Laboratory

The Company operates a veterinary diagnostic laboratory network serving all 50 states and certain areas in Canada. The Company's Laboratory revenue accounted for 16% of total revenue in 2012. The Company service a diverse customer base of over 16,000 clients, including animal! hospital! s the Company operates, which accounted for 16% of total laboratory revenue in 2012. The Company's diagnostic spectrum includes over 300 different tests in the area of chemistry, pathology, endocrinology, serology, hematology and microbiology, as well as tests specific to particular diseases. As of December 31, 2012, the Company operated 55 veterinary diagnostic laboratories. The Company's laboratory network includes primary hubs that are open 24 hours per day and offer a testing menu, secondary laboratories that are open 24 hours per day and offer a testing menu servicing large metropolitan areas, and short-term assessment and treatment (STAT) laboratories that service other locations with demand sufficient to warrant nearby laboratory facilities and are open primarily during daytime hours. In 2012, the Company derived approximately 85% of its laboratory revenue from metropolitan areas, where the Company offers twice-a-day pick-up service and same-day results. In addition, in these areas the Company generally offers to report results within three hours of pick-up. Outside of these areas, the Company typically provides test results to veterinarians before 8:00 a.m. the day following pick-up.

The Company competes with IDEXX Laboratories, Demand Force, and ePet Health.

Advisors' Opinion:

• [By Sean Williams]

  Let's also not forget about the physical surgical and veterinary centers themselves. VCA Antech (NASDAQ: WOOF  ) , for instance, operates more than 600 hospitals around the U.S., as well as 55 diagnostic laboratories. Like PetSmart, VCA hasn't seen a decline in revenue in any of the past 10 years, growing sales by 212% over that timespan thanks to growth in services rendered, ample pricing power, and strong ancillary sales of premium food and vitamins from its hospitals and veterinary centers.

5 Best Gas Utility Stocks To Invest In Right Now: Corinthian Colleges Inc (COCO)

Corinthian Colleges, Inc., incorporated on July 24, 1996, is a post-secondary education company in the United States and Canada. As of June 30, 2013, the Company had a student enrollment of 81,284 and operated 97 schools in 25 states, and 14 schools in the province of Ontario, Canada. It offers a variety of diploma programs and associate, bachelor's and master's degrees. The Company�� training program areas include healthcare, criminal justice, business, mechanical, trades, and information technology. The Company�� diploma curricula includes medical assisting, medical insurance billing and coding, massage therapy, dental assisting, pharmacy technician, medical administrative assisting, surgical technology, automotive and diesel technology, heating, ventilation, and air conditioning (HVAC), plumbing, electrical, and licensed practical nursing. Its core degree curriculum includes business administration, accounting, paralegal, criminal justice, medical assisting, and registered nursing.

Diploma programs are generally designed to have duration of approximately 8-12 months, depending on the course of study. Associate degree programs are generally designed to have duration of approximately 24-28 months, bachelor's degree programs are generally designed to have duration of approximately 48 months and master's degree programs are generally designed to have duration of approximately 21 months. As of June 30, 2013, approximately 39% of its students were enrolled in diploma programs, approximately 55% of students were enrolled in associate programs, approximately 5% of students were in bachelor's programs and approximately 1% of students were in master's programs.

The Company�� career services departments assist students in preparing resumes, help them to develop a professional demeanor and other soft skills that are important in the workplace, conduct practice interview sessions, and identify prospective employers for graduates. At the Company�� Everest locations in Florida, ! Phoenix, AZ, Mesa, AZ, Springfield, MO and Ontario Metro, CA, some of its associate degree programs also articulate into a bachelor's degree in the same course of study. Master's degrees are also offered at Everest Florida in business administration and criminal justice. As of June 30, 2013, 94 out of 111 schools were operating under the Everest brand, five schools were operating under the WyoTech brand, and 12 schools were operating under the Heald brand.

Advisors' Opinion:

• [By Ben Levisohn]

  Allegion plc (ALLE) will replace J. C. Penney Company Inc. in the S&P 500, J. C. Penney will replace A茅ropostale Inc. (ARO) in the S&P MidCap 400, and A茅ropostale will replace Corinthian Colleges Inc. (COCO) in the S&P SmallCap 600 after the close of trading on Friday, November 29.

• [By Ben Levisohn]

  Corinthian Colleges (COCO) is tumbling today after California’s attorney general filed suit against the for-profit college for “false and predatory advertising,” among other charges.

  From the AG Kamala Harris’s press release:

  The complaint alleges that CCI intentionally targeted low-income, vulnerable Californians through deceptive and false advertisements and aggressive marketing campaigns that misrepresented job placement rates and school programs. CCI deployed these advertisements through persistent internet, telemarketing and television ad campaigns. The complaint further alleges that Corinthian executives knowingly misrepresented job placement rates to investors and accrediting agencies, which harmed students, investors and taxpayers.

  The AP notes that the charges are similar to those that were filed by now-governor Jerry Brown in 2007 and were settled for $6.5 million.

  Corinthian responded in an SEC filing:

  On October 10, 2013, Corinthian Colleges, Inc. (the ��ompany,����orinthian,����e,����s��or other similar terms) was notified of a civil complaint filed against the Company and several of its subsidiaries by the California Attorney General�� Office (the ��A AG��. As previously disclosed, we have been cooperating with an investigation initiated by the CA AG in December 2012, more than nine months ago. The Company was disappointed that it was not given advance notice of the complaint, and did not have the opportunity to discuss the allegations in the complaint with the CA AG before the complaint was filed.

  The Company is committed to regulatory compliance and has robust processes in place to correctly record and disclose the job placement information we receive from our graduates and their employers. The Company is proud of the career and technical education that our 15,000 employees provide to more than 80,000 students in the United States and Canada. The Company expect

• [By MARKETWATCH]

  SAN FRANCISCO (MarketWatch) -- S&P Dow Jones Indices said late Friday that J.C. Penney (JCP) would be leaving the S&P 500 (SPX) upon the close of trading Nov. 29 after its market cap no longer made it suitable for the large-cap index of stocks. It will be replaced by Allegion, a soon-to-be-public spinoff of Ingersoll-Rand (IR) , which will remain in the S&P 500. J. C. Penney will replace A茅ropostale Inc. (ARO) in the S&P MidCap 400, which in turn will replace Corinthian Colleges (COCO) in the S&P SmallCap 600. Even including an 18% recovery in price this month, J.C. Penney shares have dropped 55% this year, leaving it with a market cap of $2.7 billion. The lowest market cap stock on the index Friday was Abercrombie & Fitch (ANF) . J.C. Penney shares fell 1% after hours.

5 Best Gas Utility Stocks To Invest In Right Now: Cytomedix Inc (CMXI)

Cytomedix, Inc. (Cytomedix), incorporated in April 29, 1998, is a regenerative therapies company marketing and developing products within the United States and internationally .The Company commercializes cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing. The Company is a commercial operation, and a robust clinical pipeline representing a logical extension of its commercial technologies in the evolving field of regenerative medicine. Cytomedix primarily operates in the United States. Its commercial offerings are centered on its point of care platform technologies for the safe and efficient separation of blood and bone marrow to produce platelet based therapies or cell concentrates.

The Company markets and selsl two distinct platelet rich plasma (PRP) technologies, the AutoloGel System for wound care and the Angel concentrated Platelet Rich Plasma (cPRP) Sytem in orthopedic and cardiovascular markets. Its clinical pipeline includes the ALDH, which are cell-based therapies (Bright Cells). In February 2012, the Company acquired Aldagen, Inc.

The AutoloGel System

The AutoloGel System is a point of care device for the production of a platelet based bioactive therapy derived from a small sample of the patient�� own blood. Using the patient�� own platelets as a therapeutic agent, AutoloGel harnesses the body�� natural healing processes to deliver growth factors, chemokines and cytokines known to promote angiogenesis and to regulate cell growth and the formation of new tissue.

Angel Product Line

The Angel concentrated Platelet Rich Plasma (cPRP) System is a multi-functional cell separation device which produces concentrated platelet rich plasma for use in the operating room and clinic and is used in a range of orthopedic and cardiovascular indications. Similar to the AutoloGel System, the Angel System is a point of care device for the production of a concentrated, aseptic platelet! -based bioactive therapy derived from a small sample of the patient�� own blood. The resulting cPRP is applied at the site of injury to promote healing. The Angel product line also includes ancillary products such as phlebotomy and applicator supplies and activAT. activAT is designed to produce autologous thrombin serum from platelet poor plasma and is sold exclusively in Europe and Canada, where it provides a safe alternative to bovine-derived products.

ALDHbr Cell Technology and Development Pipeline

The ALDHbr (Bright Cell) technology is an approach to cell-based regenerative medicine and a logical extension of its commercial technologies in the evolving regenerative medicine market, with potential clinical indications in markets with unmet medical needs such as peripheral arterial disease and ischemic stroke. The Bright Cell technology is in that it utilizes an intracellular enzyme marker to facilitate fractionation of essential regenerative cells from a patient�� bone marrow. The bone marrow fractionation process identifies and isolates active stem and progenitor cells expressing high levels of the enzyme aldehyde dehydrogenase, or ALDH, which is a key enzyme involved in the regulation of gene activities associated with cell proliferation and differentiation.

The Company�� lead product candidate, ALD-401, is an autologous preparation of Bright Cells for the post-acute treatment of ischemic stroke. ALD-401 is being evaluated in the RECOVER-Stroke clinical study, an ongoing 100-patient, double-blind, placebo-controlled Phase 2 study in patients with unilateral, cerebral ischemic stroke with an NIH stroke scale score of less than 22. An additional product candidate, ALD-301, is in clinical development for peripheral arterial disease (PAD), a condition causing reduced flow of blood and oxygen to muscles in the leg. It has completed a Phase 1/2 study of autologous ALD-301 in critical limb ischemia (CLI), a late stage condition caused by PAD. The Phase 2 PACE! (Patient! s with Intermittent Claudication Injected with ALDH Bright Cells) study is an 80 patient, double-blind, placebo-controlled clinical trial intended to demonstrate the safety and efficacy of ALD-301 (Bright Cells) in patients diagnosed with IC.

The Company competes with Harvest Technologies (a subsidiary of Terumo), Biomet, Arteriocyte, and Arthrex.

Advisors' Opinion:

• [By James E. Brumley]

  To give credit where it's due, Cytomedix, Inc. (OTCBB:CMXI) and Baxter International Inc. (NYSE:BAX) have both helped shape the landscape of the hemostasis (bleeding control) market with their products, AutoloGel and TISSELL, respectively. Arch Therapeutics Inc. (OTCBB:ARTH) has proverbially taken their concepts "up a notch", however, and its direct solution to a problem that CMXI and BAX can't quite solve may make ARTH the hottest trading candidate in the hemostasis space.

5 Best Gas Utility Stocks To Invest In Right Now: Volkswagen AG (VLKAF.PK)

Volkswagen AG is a Germany-based automobile manufacturer. The Company develops vehicles and components, and also produces and sells vehicles, in particular Volkswagen brand passenger cars and commercial vehicles. The Company consists of two divisions: Automotive and Financial Services division. The Automotive division is responsible for the development of vehicles and engines, the production and sale of passenger cars, commercial vehicles, trucks and buses, and the genuine parts business. The Financial services division's portfolio of services includes dealer and customer services in the field of financing, leasing, direct bank, insurance and fleet business. The Company's brands include Volkswagen, Audi, Bentley, Bugatti, Lamborghini, SEAT, Skoda, Scania and Volkswagen Commercial Vehicles and each brand offers a product range from low-consumption small cars to luxury class vehicles, as well as pick ups, busses and heavy trucks in the commercial vehicle sector. Advisors' Opinion:

• [By Yasir Idrees]

  Nokia has already taken its Here platform to the next level after it announced the Here Connected Driving service. The Here rebranding strategy of extending Nokia's location services has helped the company reach deals with companies like BMW, Mercedes and Volkswagen (VLKAF.PK) and Connected Driving is what takes this to the next level.

5 Best Gas Utility Stocks To Invest In Right Now: Sterlite Industries(India)

Sterlite Industries (India) Limited operates as a non-ferrous metals and mining company in India and internationally. It engages in the smelting and processing of copper and production of copper byproducts. The company?s primary products consist of copper cathode and continuos cast rods, as well as by products comprise sulphuric acid, phosphoric acid, hydrofluoro silicic acid, gypsum, ferro sand, and slime. It also owns the Mt. Lyell copper mine at Tasmania in Australia, as well as owns various zinc assets, including Skorpion Zinc in Namibia; Black Mountain Mines in South Africa; and Lisheen Mines in Ireland. In addition, the company produces aluminum from its bauxite mines. Its aluminum products include aluminum ingots and wire rods; rolled products, such as coils and sheets; and vanadium sludge as a by-product. Further, the company smelts and produces lead and zinc, as well as produces and sells sulphuric acid to fertilizer manufacturers and other industries; and silver ingots primarily to industrial users. It operates three lead-zinc mines in the state of Rajasthan, northwest India. Additionally, it involves in power generations business. As of March 31, 2011, the company had a power generation capacity of 1,041 MW from its thermal power plants and wind power plants. The company was formerly known as Sterlite Cables Limited and changed its name to Sterlite Industries (India) Limited in 1986.The company was incorporated 1975 and is based in Mumbai, India. Sterlite Industries (India) Limited is a subsidiary of Vedanta Resources plc.

Advisors' Opinion:

• [By Rajhkumar K Shaaw]

  BNP Paribas Securities (Asia) Ltd., Macquarie Capital Securities (India) Pvt. and Ambit Capital Pvt. cut their Sensex targets as the Reserve Bank of India unexpectedly increased its benchmark interest rate to stem a record decline in the rupee and curb consumer prices in the world�� second-most populous nation. Strategists reduced their average profit estimate by 4.5 percent as higher borrowing costs threaten to worsen the slowest economic expansion since 2009.

5 Best Gas Utility Stocks To Invest In Right Now: SanDisk Corporation(SNDK)

Sandisk Corporation designs, develops, and manufactures NAND flash memory storage solutions that are used in various consumer electronics products. The company offers removable cards under the SanDisk Ultra, SanDisk Extreme, and SanDisk Extreme PRO brands; embedded products under the iNAND brand; universal serial bus (USB) flash drives under the Cruzer brand; digital media players under the Sansa brand; solid state drives under the Lightning brand; and wafers and memory components. Its removable card products are used in a range of consumer electronics devices, including mobile phones, digital cameras, gaming devices, and laptop computers; and embedded flash products are used in mobile phones, tablets, ultrabooks, eReaders, global positioning system devices, gaming systems, imaging devices, and computing platforms. The company also provides high-capacity storage solutions, such as solid-state drives that are used in lieu of hard disk drives. It offers its products to the m obile phone, consumer electronics, and computing end markets through original equipment manufacturers, distributors, and retail sales channels in the Americas, the Asia Pacific, Europe, the Middle East, Africa, and Japan. The company was formerly known as SunDisk Corporation and changed its name to SanDisk Corporation in August 1995. SanDisk Corporation was founded in 1988 and is headquartered in Milpitas, California.

Advisors' Opinion:

• [By Benjamin Pimentel]

  Apple (AAPL) �shed 0.5% to close at $520.03 as the company�� new iPad Air hit the stores. Chip stocks also retreated, led by Intel Corp. (INTC) , Texas Instruments (TXN) , Advanced Micro Devices (AMD) and SanDisk (SNDK) .

5 Best Gas Utility Stocks To Invest In Right Now: Dr. Reddy's Laboratories Ltd(RDY)

Dr. Reddy?s Laboratories Limited, together with its subsidiaries, operates as a pharmaceutical company. It produces finished dosage forms, active pharmaceutical ingredients and intermediates, and biotechnology products. The company also conducts research in the areas of cancer, diabetes, cardiovascular, inflammation, and bacterial infection. In addition, it involves in the contract manufacture generic prescription and over-the-counter products for branded and generic companies in the United States. The company primarily focuses on therapeutic categories of cardiovascular, diabetes management, gastro-intestinal, and pain management. It markets its products in India, the United States, Europe, and the Russian Federation. The company has a co-development and commercialization agreement with Rheoscience A/S for the development and commercialization of Balaglitazone/DRF 2593, a partial PPAR-gamma agonist for the treatment of type 2 diabetes; an agreement with ClinTec Internatio nal for the development of an anti-cancer compound, DRF 1042; collaboration with the National Cancer Institute in Maryland; and an agreement with Argenta Discovery Limited for the joint development and commercialization of a novel approach to the treatment of chronic obstructive pulmonary disease. It also has an agreement with 7TM Pharma for drug discovery collaboration on selected drug targets; and an agreement with GlaxoSmithKline plc to develop and market pharmaceuticals for the treatment of cardiovascular disease, diabetes, oncology, gastroenterology, and pain management. Dr. Reddy?s Laboratories Limited was founded in 1984 and is headquartered in Hyderabad, India.

Advisors' Opinion:

• [By Benjamin Shepherd] We’re now into day 15 of the US government shutdown, as House Republicans stubbornly try to defund Obamacare. No matter what sort of deal is eventually struck, health care costs aren’t likely to come down any time soon. And that’s good news for generic drug makers.
  
  Dr. Reddy’s Laboratories (NYSE: RDY) is one of the biggest players in generic drugs, offering more than 200 off-brand medications in the areas of cardiovascular disease, pain management and oncology, among others. In fact, this India-based company has become one of the largest makers of generics in the world, helping to drive more than 20 percent annual compounded earnings growth at the company over the past decade.